Antipsychotic withdrawal: rebound and supersensitivity

Antipsychotic withdrawal is real, under-discussed, and often misread. When a patient who has been on a dopamine-blocking medication for months or years reduces the dose or stops, the body responds. Sometimes the response is mild and transient. Sometimes it looks like the original illness coming back — and sometimes it actually is the original illness coming back. Telling these apart matters because the right next step is different in each case.

Three categories of withdrawal phenomena

1. Discontinuation symptoms

These are non-psychotic symptoms that appear when the antipsychotic is reduced or stopped, particularly with agents that have strong cholinergic blockade (olanzapine, quetiapine, clozapine):

• Insomnia, vivid dreams
• Nausea, vomiting, diarrhea
• Sweating, runny nose
• Anxiety, restlessness
• Headache, dizziness
• Flu-like feeling

These usually peak within the first 1–2 weeks and resolve within 2–4 weeks. Slower tapers reduce their intensity. They are uncomfortable, not dangerous.

2. Rebound psychosis (supersensitivity psychosis)

Long-term D2 blockade leads to upregulation of dopamine receptors — the brain compensates by making more receptors. When the blocker is removed, the now-numerous receptors are exposed to normal dopamine levels and respond more strongly than they would have before treatment. The clinical result can be a return of psychotic symptoms that may be more intense than the original presentation.

The concept of "supersensitivity psychosis" was first articulated by Chouinard and Jones in the 1980s and has become more accepted with modern receptor imaging. It is more common with high-potency D2 blockers and with rapid discontinuation.

3. Withdrawal dyskinesia

Involuntary movements — often of the face, mouth, or limbs — that emerge or worsen during dose reduction. Mechanistically related to tardive dyskinesia. Sometimes they resolve as the brain adapts; sometimes they persist. See our tardive dyskinesia article.

How to tell withdrawal from relapse

This is the central clinical question of any taper. Some markers that lean one way or the other:

• Timing: Discontinuation symptoms appear within days to a week. Withdrawal dyskinesia often within weeks. Rebound psychosis can appear within days to weeks. True relapse from underlying illness is more variable, often weeks to months.
• Symptom pattern: Discontinuation symptoms are physical (GI, sleep, autonomic) and rarely include voices or delusions. A return of voices, paranoia, or thought disorder points toward rebound or relapse.
• Resemblance to past episodes: If the symptoms look like prior psychotic episodes the patient has had, relapse is more likely. If they are sharper or more intense than past episodes, supersensitivity is on the differential.
• Trajectory: Discontinuation symptoms generally get better over 2–4 weeks. Untreated psychotic symptoms generally do not.

This distinction is rarely clean. Many real-world cases involve overlap. The practical approach is usually to pause the taper, restart contact with the prescribing team, and re-evaluate after 1–2 weeks at the current dose.

Cholinergic rebound

Antipsychotics with strong anticholinergic activity — clozapine, olanzapine, quetiapine, chlorpromazine — can produce a particularly distinctive withdrawal: cholinergic rebound. The blocked acetylcholine system, suddenly unblocked, fires more strongly than normal. Symptoms include nausea, vomiting, diarrhea, sweating, headache, and insomnia. Slower tapers and, in some cases, short-term anticholinergic bridge medications can blunt it.

Supersensitivity psychosis: what we know and don't

Two patterns have been described in the literature:

• Withdrawal supersensitivity: psychotic symptoms emerging in the days to weeks after discontinuation, sometimes resolving as receptors readapt
• Treatment-resistant supersensitivity: a longer-term shift in which psychotic symptoms appear even at previously effective doses, requiring higher doses or different agents

The clinical reality is messier than the categories suggest. Modern tapering trials have not consistently shown a distinct supersensitivity pattern at the population level, but individual cases that fit the description are seen often enough that the concept remains useful clinically.

How to reduce withdrawal risk

• Taper slowly. The gold standard is a hyperbolic taper, with smaller dose decrements as the dose gets lower. See our tapering guide.
• Don't stop abruptly unless there is a medical urgency such as a serious adverse reaction.
• Keep early warning sign monitoring active. Sleep changes, voices, suspicion — track them.
• Have a written re-engagement plan. Decide in advance what symptoms would trigger pausing or reversing the taper.
• Tell trusted people. Family, partners, or friends who know the plan can spot warning signs the patient may miss.

What if you have already stopped abruptly?

Stopping cold-turkey happens — through hospital discharge errors, lost prescriptions, financial problems, or personal decision. If this has happened:

• Contact a prescriber as soon as possible
• Resume the previous medication if possible while a new plan is built
• Note what you are experiencing, when it started, and how it is changing
• Use crisis lines — 988 — if symptoms are escalating

The big picture

Antipsychotic withdrawal is a normal physiological response to a long course of dopamine receptor blockade. It does not mean the medication was a mistake, and it does not mean the patient is doomed to stay on it forever. It means the brain has adapted, and reversing the adaptation needs to be done with care. Slow tapers, good monitoring, and an honest conversation about what to expect are the tools that turn a risky transition into a manageable one.

For more, see antipsychotic discontinuation, tapering antipsychotics, and relapse prevention plans.

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.